Synthetic lethality induced by loss of PKC δ and mutated ras

Genes and Cancer

Volumn 1, Issue 2, 2010, Pages 142-151

  Zhu, Tongbo ^a   Chen, Lihua ^a   Du, Wei ^a   Tsuji, Takanori ^a   Chen, Changyan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

JNK; PKC; RACKI; Ras; Synthetic lethality

Indexed keywords

CASPASE 8; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; RAS PROTEIN; RECEPTOR FOR ACTIVATED C KINASE 1; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 79952840742     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601909360989     Document Type: Article

References (45)

1. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-96.
2. Spitaler M, Cantrell DA. Protein kinase C and beyond. Nat Immunol 2004;5:785-90.
3. Reyland ME. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 2009;14:2386-99.
4. Gutcher I, Webb PR, Anderson NG. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 2003;60:1061-70.
5. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000;279:429-38.
6. Meinhardt G, Roth J, Totok G. Protein kinase C activation modulates proand anti-apoptotic signaling pathways. Eur J Cell Biol 2000;79:824-33.
7. Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 2001;101:2353-64.
8. Knox KA, Johnson GD, Gordon J. A study of protein kinase C isozyme distribution in relation to Bcl-2 expression during apoptosis of epithelial cells in vivo. Exp Cell Res 1993;207:68-73.
9. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD, Fair WR. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 1996;7:419-28.
10. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, et al. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 1996;184:2399-404.
11. Khwaja A, Tatton L. Caspase-mediated proteolysis and activation of protein kinase Cdelta plays a central role in neutrophil apoptosis. Blood 1999;94:291-301.
12. Matassa AA, Carpenter L, Biden TJ, Humphries MJ, Reyland ME. PKCdelta is required for mitochondrial-dependent apoptosis in salivary epithelial cells. J Biol Chem 2001;276:29719-28.
13. Majumder PK, Mishra NC, Sun X, Bharti A, Kharbanda S, Saxena S, et al. Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ 2001;12:465-70.
14. Zhu T, Tsuji T, Chen CY. Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras. Oncogene 2009. Epub ahead of print.
15. Xia S, Forman LW, Faller DV. Protein kinase C delta is required for survival of cells expressing activated p21RAS. J Biol Chem 2007;282:13199-210.
16. Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci USA 1994;91:839-43.
17. Schechtman D, Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 2001;20:6339-47.
18. Buchner K. The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J Cancer Res Clin Oncol 2000;126:1-11.
19. Mayer C, Grummt I. Cellular stress and nucleolar function. Cell Cycle 2005;4:1036-8.
20. Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene 2008;27:6245-51.
21. Whitmarsh AJ, Davis RJ. Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 2007;26:3172-84.
22. Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol 2007;19:142-9.
23. Han J, Shui JW, Zhang X, Zheng B, Han S, Tan TH. HIP-55 is important for T-cell proliferation, cytokine production, and immune responses. Mol Cell Biol 2005;25:6869-78.
24. Sluss HK, Barrett T, Derijard B, Davis RJ. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 1994;14:8376-84.
25. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025-37.
26. Chen CY, Liou J, Forman LW, Faller DV. Differential regulation of discrete apoptotic pathways by Ras. J Biol Chem 1998;273:16700-9.
27. Chen CY, Juo P, Liou JS, Li CQ, Yu Q, Blenis J, et al. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis. Cell Growth Differ 2001;12:297-306.
28. Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z. RACK1 mediates activation of JNK by protein kinase C[corrected]. Mol Cell 2005;19:309-20.
29. Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH. Integrating genetic approaches into the discovery of anticancer drugs. Science 1997;278:1064-8.
30. Kaelin WG Jr. The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 2005;5:689-98.
31. Sawyers CL. Finding and drugging the vulnerabilities of RASdependent cancers. Cell 2009;137:796-8.
32. Scholl C, Frohling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009;137:821-34.
33. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009;137:835-48.
34. Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G, et al. A lossof- function RNA interference screen for molecular targets in cancer. Nature 2006;441:106-10.
35. Ron D, Jiang Z, Yao L, Vagts A, Diamond I, Gordon A. Coordinated movement of RACK1 with activated betaIIPKC. J Biol Chem 1999;274:27039-46.
36. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007;7:281-94.
37. Afrasiabi E, Ahlgren J, Bergelin N, Tornquist K. Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCdelta. Mol Cell Endocrinol 2008;292:26-35.
38. Yin L, Bennani-Baiti N, Powell CT. Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway. J Biol Chem 2005;280:5533-41.
39. Paone A, Starace D, Galli R, Padula F, De CP, Filippini A, et al. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis 2008;29:1334-42.
40. Matassa AA, Kalkofen RL, Carpenter L, Biden TJ, Reyland ME. Inhibition of PKCalpha induces a PKCdelta-dependent apoptotic program in salivary epithelial cells. Cell Death Differ 2003;10:269-77.
41. Guo J, Zhu T, Luo LY, Huang Y, Sunkavalli RG, Chen CY. PI3K acts in synergy with loss of PKC to elicit apoptosis via the UPR. J Cell Biochem 2009;107:76-85.
42. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-31.
43. Downward J. Ras signalling and apoptosis. Curr Opin Genet Dev 1998;8:49-54.
44. Ma P, Magut M, Faller DV, Chen CY. The role of Ras in T lymphocyte activation. Cell Signal 2002;14:849-59.
45. Smakman N, van den Wollenberg DJ, Elias SG, Sasazuki T, Shirasawa S, Hoeben RC, et al. KRAS(D13) promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2006;66:5403-8.